Recent Advances in Cell Membrane‐Derived Biomimetic Nanotechnology for Cancer Immunotherapy
Immunotherapy will significantly impact the standard of care in cancer treatment. Recent advances in nanotechnology can improve the efficacy of cancer immunotherapy. However, concerns regarding efficiency of cancer nanomedicine, complex tumor microenvironment, patient heterogeneity, and systemic imm...
Gespeichert in:
| Veröffentlicht in: | Advanced healthcare materials 2021-03, Vol.10 (6), p.e2002081-n/a |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | n/a |
|---|---|
| container_issue | 6 |
| container_start_page | e2002081 |
| container_title | Advanced healthcare materials |
| container_volume | 10 |
| creator | Raza, Faisal Zafar, Hajra Zhang, Shulei Kamal, Zul Su, Jing Yuan, Wei‐En Mingfeng, Qiu |
| description | Immunotherapy will significantly impact the standard of care in cancer treatment. Recent advances in nanotechnology can improve the efficacy of cancer immunotherapy. However, concerns regarding efficiency of cancer nanomedicine, complex tumor microenvironment, patient heterogeneity, and systemic immunotoxicity drive interest in more novel approaches to be developed. For this purpose, biomimetic nanoparticles are developed to make innovative changes in the delivery and biodistribution of immunotherapeutics. Biomimetic nanoparticles have several advantages that can advance the clinical efficacy of cancer immunotherapy. Thus there is a greater push toward the utilization of biomimetic nanotechnology for developing effective cancer immunotherapeutics that demonstrate increased specificity and potency. The recent works and state‐of‐the‐art strategies for anti‐tumor immunotherapeutics are highlighted here, and particular emphasis has been given to the applications of cell‐derived biomimetic nanotechnology for cancer immunotherapy.
Biomimetic nanotechnology has considerable scope for cancer immunotherapy. The optimized development of biomimetic nanoparticles can actively enhance the therapeutic efficacy of cancer immunotherapy. The review attempts to provide a brief overview of this emerging area, where biomimetic nanoparticles has been used in the field of immunotherapy for cancer treatment. It highlights the recent developments in immunotherapeutics based on cell membrane‐derived biomimetic nanoparticles and its related applications in cancer. |
| doi_str_mv | 10.1002/adhm.202002081 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2501878665</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2501878665</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4391-fac26080faf77c041fa22e05e8febe07c32267320eeef48f4cb86f4771f7276b3</originalsourceid><addsrcrecordid>eNqFkLFOwzAQhi0Eoqh0ZUSWmFtsJ7GdsaRAK7UgIRhR5DhnmiqJi5MUZeMReEaehFQtZeSWO-m-_7_Tj9AFJSNKCLtW6bIYMcK6mUh6hM4YDdmQ8SA8Psw-6aFBVa1IVzygXNJT1PO8QHKPsTP0-gQayhqP040qNVQ4K3EEeY4XUCROlfD9-TUBl20gxTeZLbIC6kzjB1XaGvSytLl9a7GxDkdbvcOzomi63RKcWrfn6MSovILBvvfRy93tczQdzh_vZ9F4PtS-F9KhUZpxIolRRghNfGoUY0ACkAYSIEJ3r3LhMQIAxpfG14nkxheCGsEET7w-utr5rp19b6Cq45VtXNmdjFlAqBSS86CjRjtKO1tVDky8dlmhXBtTEm8DjbeBxodAO8Hl3rZJCkgP-G98HRDugI8sh_Yfu3g8mS7-zH8AzvuC3A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2501878665</pqid></control><display><type>article</type><title>Recent Advances in Cell Membrane‐Derived Biomimetic Nanotechnology for Cancer Immunotherapy</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Raza, Faisal ; Zafar, Hajra ; Zhang, Shulei ; Kamal, Zul ; Su, Jing ; Yuan, Wei‐En ; Mingfeng, Qiu</creator><creatorcontrib>Raza, Faisal ; Zafar, Hajra ; Zhang, Shulei ; Kamal, Zul ; Su, Jing ; Yuan, Wei‐En ; Mingfeng, Qiu</creatorcontrib><description>Immunotherapy will significantly impact the standard of care in cancer treatment. Recent advances in nanotechnology can improve the efficacy of cancer immunotherapy. However, concerns regarding efficiency of cancer nanomedicine, complex tumor microenvironment, patient heterogeneity, and systemic immunotoxicity drive interest in more novel approaches to be developed. For this purpose, biomimetic nanoparticles are developed to make innovative changes in the delivery and biodistribution of immunotherapeutics. Biomimetic nanoparticles have several advantages that can advance the clinical efficacy of cancer immunotherapy. Thus there is a greater push toward the utilization of biomimetic nanotechnology for developing effective cancer immunotherapeutics that demonstrate increased specificity and potency. The recent works and state‐of‐the‐art strategies for anti‐tumor immunotherapeutics are highlighted here, and particular emphasis has been given to the applications of cell‐derived biomimetic nanotechnology for cancer immunotherapy.
Biomimetic nanotechnology has considerable scope for cancer immunotherapy. The optimized development of biomimetic nanoparticles can actively enhance the therapeutic efficacy of cancer immunotherapy. The review attempts to provide a brief overview of this emerging area, where biomimetic nanoparticles has been used in the field of immunotherapy for cancer treatment. It highlights the recent developments in immunotherapeutics based on cell membrane‐derived biomimetic nanoparticles and its related applications in cancer.</description><identifier>ISSN: 2192-2640</identifier><identifier>EISSN: 2192-2659</identifier><identifier>DOI: 10.1002/adhm.202002081</identifier><identifier>PMID: 33586322</identifier><language>eng</language><publisher>Germany: Wiley Subscription Services, Inc</publisher><subject>biomimetic nanoparticles ; Biomimetics ; Cancer ; Cancer immunotherapy ; Cell Membrane ; Cell membranes ; effective drug delivery ; Heterogeneity ; Humans ; Immunotherapy ; Immunotoxicity ; Nanomedicine ; Nanoparticles ; Nanotechnology ; Neoplasms - therapy ; Tissue Distribution ; Tumor Microenvironment ; Tumors</subject><ispartof>Advanced healthcare materials, 2021-03, Vol.10 (6), p.e2002081-n/a</ispartof><rights>2021 Wiley‐VCH GmbH</rights><rights>2021 Wiley-VCH GmbH.</rights><rights>2021 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4391-fac26080faf77c041fa22e05e8febe07c32267320eeef48f4cb86f4771f7276b3</citedby><cites>FETCH-LOGICAL-c4391-fac26080faf77c041fa22e05e8febe07c32267320eeef48f4cb86f4771f7276b3</cites><orcidid>0000-0003-4177-7812</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fadhm.202002081$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fadhm.202002081$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33586322$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Raza, Faisal</creatorcontrib><creatorcontrib>Zafar, Hajra</creatorcontrib><creatorcontrib>Zhang, Shulei</creatorcontrib><creatorcontrib>Kamal, Zul</creatorcontrib><creatorcontrib>Su, Jing</creatorcontrib><creatorcontrib>Yuan, Wei‐En</creatorcontrib><creatorcontrib>Mingfeng, Qiu</creatorcontrib><title>Recent Advances in Cell Membrane‐Derived Biomimetic Nanotechnology for Cancer Immunotherapy</title><title>Advanced healthcare materials</title><addtitle>Adv Healthc Mater</addtitle><description>Immunotherapy will significantly impact the standard of care in cancer treatment. Recent advances in nanotechnology can improve the efficacy of cancer immunotherapy. However, concerns regarding efficiency of cancer nanomedicine, complex tumor microenvironment, patient heterogeneity, and systemic immunotoxicity drive interest in more novel approaches to be developed. For this purpose, biomimetic nanoparticles are developed to make innovative changes in the delivery and biodistribution of immunotherapeutics. Biomimetic nanoparticles have several advantages that can advance the clinical efficacy of cancer immunotherapy. Thus there is a greater push toward the utilization of biomimetic nanotechnology for developing effective cancer immunotherapeutics that demonstrate increased specificity and potency. The recent works and state‐of‐the‐art strategies for anti‐tumor immunotherapeutics are highlighted here, and particular emphasis has been given to the applications of cell‐derived biomimetic nanotechnology for cancer immunotherapy.
Biomimetic nanotechnology has considerable scope for cancer immunotherapy. The optimized development of biomimetic nanoparticles can actively enhance the therapeutic efficacy of cancer immunotherapy. The review attempts to provide a brief overview of this emerging area, where biomimetic nanoparticles has been used in the field of immunotherapy for cancer treatment. It highlights the recent developments in immunotherapeutics based on cell membrane‐derived biomimetic nanoparticles and its related applications in cancer.</description><subject>biomimetic nanoparticles</subject><subject>Biomimetics</subject><subject>Cancer</subject><subject>Cancer immunotherapy</subject><subject>Cell Membrane</subject><subject>Cell membranes</subject><subject>effective drug delivery</subject><subject>Heterogeneity</subject><subject>Humans</subject><subject>Immunotherapy</subject><subject>Immunotoxicity</subject><subject>Nanomedicine</subject><subject>Nanoparticles</subject><subject>Nanotechnology</subject><subject>Neoplasms - therapy</subject><subject>Tissue Distribution</subject><subject>Tumor Microenvironment</subject><subject>Tumors</subject><issn>2192-2640</issn><issn>2192-2659</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkLFOwzAQhi0Eoqh0ZUSWmFtsJ7GdsaRAK7UgIRhR5DhnmiqJi5MUZeMReEaehFQtZeSWO-m-_7_Tj9AFJSNKCLtW6bIYMcK6mUh6hM4YDdmQ8SA8Psw-6aFBVa1IVzygXNJT1PO8QHKPsTP0-gQayhqP040qNVQ4K3EEeY4XUCROlfD9-TUBl20gxTeZLbIC6kzjB1XaGvSytLl9a7GxDkdbvcOzomi63RKcWrfn6MSovILBvvfRy93tczQdzh_vZ9F4PtS-F9KhUZpxIolRRghNfGoUY0ACkAYSIEJ3r3LhMQIAxpfG14nkxheCGsEET7w-utr5rp19b6Cq45VtXNmdjFlAqBSS86CjRjtKO1tVDky8dlmhXBtTEm8DjbeBxodAO8Hl3rZJCkgP-G98HRDugI8sh_Yfu3g8mS7-zH8AzvuC3A</recordid><startdate>20210301</startdate><enddate>20210301</enddate><creator>Raza, Faisal</creator><creator>Zafar, Hajra</creator><creator>Zhang, Shulei</creator><creator>Kamal, Zul</creator><creator>Su, Jing</creator><creator>Yuan, Wei‐En</creator><creator>Mingfeng, Qiu</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QF</scope><scope>7QP</scope><scope>7QQ</scope><scope>7SC</scope><scope>7SE</scope><scope>7SP</scope><scope>7SR</scope><scope>7T5</scope><scope>7TA</scope><scope>7TB</scope><scope>7TM</scope><scope>7TO</scope><scope>7U5</scope><scope>8BQ</scope><scope>8FD</scope><scope>F28</scope><scope>FR3</scope><scope>H8D</scope><scope>H8G</scope><scope>H94</scope><scope>JG9</scope><scope>JQ2</scope><scope>K9.</scope><scope>KR7</scope><scope>L7M</scope><scope>L~C</scope><scope>L~D</scope><orcidid>https://orcid.org/0000-0003-4177-7812</orcidid></search><sort><creationdate>20210301</creationdate><title>Recent Advances in Cell Membrane‐Derived Biomimetic Nanotechnology for Cancer Immunotherapy</title><author>Raza, Faisal ; Zafar, Hajra ; Zhang, Shulei ; Kamal, Zul ; Su, Jing ; Yuan, Wei‐En ; Mingfeng, Qiu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4391-fac26080faf77c041fa22e05e8febe07c32267320eeef48f4cb86f4771f7276b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>biomimetic nanoparticles</topic><topic>Biomimetics</topic><topic>Cancer</topic><topic>Cancer immunotherapy</topic><topic>Cell Membrane</topic><topic>Cell membranes</topic><topic>effective drug delivery</topic><topic>Heterogeneity</topic><topic>Humans</topic><topic>Immunotherapy</topic><topic>Immunotoxicity</topic><topic>Nanomedicine</topic><topic>Nanoparticles</topic><topic>Nanotechnology</topic><topic>Neoplasms - therapy</topic><topic>Tissue Distribution</topic><topic>Tumor Microenvironment</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Raza, Faisal</creatorcontrib><creatorcontrib>Zafar, Hajra</creatorcontrib><creatorcontrib>Zhang, Shulei</creatorcontrib><creatorcontrib>Kamal, Zul</creatorcontrib><creatorcontrib>Su, Jing</creatorcontrib><creatorcontrib>Yuan, Wei‐En</creatorcontrib><creatorcontrib>Mingfeng, Qiu</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Aluminium Industry Abstracts</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Ceramic Abstracts</collection><collection>Computer and Information Systems Abstracts</collection><collection>Corrosion Abstracts</collection><collection>Electronics & Communications Abstracts</collection><collection>Engineered Materials Abstracts</collection><collection>Immunology Abstracts</collection><collection>Materials Business File</collection><collection>Mechanical & Transportation Engineering Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Solid State and Superconductivity Abstracts</collection><collection>METADEX</collection><collection>Technology Research Database</collection><collection>ANTE: Abstracts in New Technology & Engineering</collection><collection>Engineering Research Database</collection><collection>Aerospace Database</collection><collection>Copper Technical Reference Library</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Materials Research Database</collection><collection>ProQuest Computer Science Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Civil Engineering Abstracts</collection><collection>Advanced Technologies Database with Aerospace</collection><collection>Computer and Information Systems Abstracts Academic</collection><collection>Computer and Information Systems Abstracts Professional</collection><jtitle>Advanced healthcare materials</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Raza, Faisal</au><au>Zafar, Hajra</au><au>Zhang, Shulei</au><au>Kamal, Zul</au><au>Su, Jing</au><au>Yuan, Wei‐En</au><au>Mingfeng, Qiu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Recent Advances in Cell Membrane‐Derived Biomimetic Nanotechnology for Cancer Immunotherapy</atitle><jtitle>Advanced healthcare materials</jtitle><addtitle>Adv Healthc Mater</addtitle><date>2021-03-01</date><risdate>2021</risdate><volume>10</volume><issue>6</issue><spage>e2002081</spage><epage>n/a</epage><pages>e2002081-n/a</pages><issn>2192-2640</issn><eissn>2192-2659</eissn><abstract>Immunotherapy will significantly impact the standard of care in cancer treatment. Recent advances in nanotechnology can improve the efficacy of cancer immunotherapy. However, concerns regarding efficiency of cancer nanomedicine, complex tumor microenvironment, patient heterogeneity, and systemic immunotoxicity drive interest in more novel approaches to be developed. For this purpose, biomimetic nanoparticles are developed to make innovative changes in the delivery and biodistribution of immunotherapeutics. Biomimetic nanoparticles have several advantages that can advance the clinical efficacy of cancer immunotherapy. Thus there is a greater push toward the utilization of biomimetic nanotechnology for developing effective cancer immunotherapeutics that demonstrate increased specificity and potency. The recent works and state‐of‐the‐art strategies for anti‐tumor immunotherapeutics are highlighted here, and particular emphasis has been given to the applications of cell‐derived biomimetic nanotechnology for cancer immunotherapy.
Biomimetic nanotechnology has considerable scope for cancer immunotherapy. The optimized development of biomimetic nanoparticles can actively enhance the therapeutic efficacy of cancer immunotherapy. The review attempts to provide a brief overview of this emerging area, where biomimetic nanoparticles has been used in the field of immunotherapy for cancer treatment. It highlights the recent developments in immunotherapeutics based on cell membrane‐derived biomimetic nanoparticles and its related applications in cancer.</abstract><cop>Germany</cop><pub>Wiley Subscription Services, Inc</pub><pmid>33586322</pmid><doi>10.1002/adhm.202002081</doi><tpages>27</tpages><orcidid>https://orcid.org/0000-0003-4177-7812</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2192-2640 |
| ispartof | Advanced healthcare materials, 2021-03, Vol.10 (6), p.e2002081-n/a |
| issn | 2192-2640 2192-2659 |
| language | eng |
| recordid | cdi_proquest_journals_2501878665 |
| source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
| subjects | biomimetic nanoparticles Biomimetics Cancer Cancer immunotherapy Cell Membrane Cell membranes effective drug delivery Heterogeneity Humans Immunotherapy Immunotoxicity Nanomedicine Nanoparticles Nanotechnology Neoplasms - therapy Tissue Distribution Tumor Microenvironment Tumors |
| title | Recent Advances in Cell Membrane‐Derived Biomimetic Nanotechnology for Cancer Immunotherapy |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T10%3A45%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Recent%20Advances%20in%20Cell%20Membrane%E2%80%90Derived%20Biomimetic%20Nanotechnology%20for%20Cancer%20Immunotherapy&rft.jtitle=Advanced%20healthcare%20materials&rft.au=Raza,%20Faisal&rft.date=2021-03-01&rft.volume=10&rft.issue=6&rft.spage=e2002081&rft.epage=n/a&rft.pages=e2002081-n/a&rft.issn=2192-2640&rft.eissn=2192-2659&rft_id=info:doi/10.1002/adhm.202002081&rft_dat=%3Cproquest_cross%3E2501878665%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2501878665&rft_id=info:pmid/33586322&rfr_iscdi=true |